Humane Technologies Limited (HTL) has announced that it has successfully developed a prototype for the next generation of its microbial growth measurement device, the MicrobeMeter.
A new cryoprotectant polymer that dramatically improves the freezing of cells, has been discovered by researchers at the University of Warwick. The new polymers can reduce the amount of organic solvent required in cryopreservation (freezing cells) as well as giving more and healthier cells after thawing. Findings may help reduce cost and improve distribution of cells for cell-based therapies, diagnostics and research
Medherant, a spin-out company from the University of Warwick developing an innovative transdermal drug delivery patch technology, has raised £3.8 million in its latest funding round.
The University of Warwick is celebrating the continued success of its spinout Interface Polymers, following the company’s most recent investment of £2m led by private capital investment group 24Haymarket.
Meherant, which is developing a novel transdermal drug delivery patch technology, is one of 40 companies shortlisted in the competition. Shortlisted entrants will pitch their ideas to a panel of experts in front of a live audience at the RSC’s annual flagship event for industry, Chemistry Means Business. This event will be held in Manchester, UK on the 13th and 14th June 2017, where a winner will be selected.
Anti-freeze polymers designed by the University of Warwick have been launched into high altitude as part of a successful NASA-funded project in the USA.
A novel, though fictitious, method for cryogenically preserving British strawberries won top prize in a business competition for postgraduate researchers.
Run by the University of Warwick’s Science Park and supported by Warwick Ventures, the contest was the culmination of a Business Innovation and Commercialisation course aimed at PhD researchers in the Science Faculty.
No longer side-lined as a computationally-hungry scientific curiosity, two-dimensional mass spectrometry is becoming a fully-fledged analytical technique. Dr Maria van Agthoven explains to Laboratory News how the device she and Professor Peter O'Connor have invented, in the Department of Chemistry, could make this technique widely available for the first time, leading to a revolution in the pharmacuetical and biomedical communities.
Pharmaceutical research could be quicker and more precise, thanks to an innovative breakthrough in the analytical sciences from the University of Warwick.
Professor Peter O’Connor and Dr Maria van Agthoven in the Department of Chemistry have invented a device which makes 2D mass spectrometry - an effective process for analysing and sequencing proteins - widely accessible for the first time ever.
Chemistry and Warwick Ventures pilot the way to develop Early Career Researchers and win £500k to achieve Impact
Researchers in the Department of Chemistry have achieved the holy grail of making commodity plastics that can be more easily mixed, painted and joined.